Comparing antiplatelet therapies after carotid artery stenting in high bleeding risk patients

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to evaluate the safety and efficacy of dual antiplatelet therapy (DAPT) versus single antiplatelet therapy (SAPT) in patients with carotid artery disease who are at high risk for bleeding. Participants will be randomly assigned to receive either one month of DAPT followed by 11 months of SAPT or continue with DAPT for the entire 12 months post-stenting. The primary focus is on clinically significant bleeding events and the prevention of cardiovascular and cerebrovascular accidents. The study will include patients aged 19 and older with significant carotid artery stenosis scheduled for stenting.

Why it matters

Who can join: the full rules

Inclusion Criteria:

1. Patients ≥19 years
2. Symptomatic patients with carotid artery stenosis\* greater than 50% and asymptomatic patients with carotid artery stenosis\* greater than 70% who are scheduled to undergo or who have undergone carotid artery stenting
3. High bleeding risk is defined as a Bleeding Academic Research Consortium type 3 or 5 bleeding risk of ≥4% at 1 year or a risk of an intracranial hemorrhage (ICH) of ≥1% at 1 year, Patients who meet at least one of the criteria for high bleeding risk\*\* below

   * The degree of stenosis is determined using the method performed in the North American Symptomatic Carotid Endarterectomy Trial.

     * Criteria for high bleeding risk (≥ 1)

       * Incidence of non-access site bleeding within 12 months prior to stenting (gastrointestinal tract or hematuria)
       * Presence of BARC type 3 or 5 bleeding regardless of the onset time, but the cause has not been completely cured.
       * Adults aged ≥75 years
       * Thrombocytopenia \< 100,000/mm3 (based on the screening test)
       * Blood clotting disorders that increase bleeding (Von Willebrand disease, factor VII, VIII, IX, and XI deficiency)
       * Patients with anemia defined as hemoglobin \<12g/dL in men and \<11g/dL in women or patients who donated blood within 4 weeks (based on the screening test)
       * Patients received steroids or NSAIDs for ≥4 weeks
       * Patients with active malignancy (except for nonmelanoma skin cancer)
       * Renal disease (dialysis, transplantation, Estimated Glomerular Filtration Rate \< 60ml/min per 1.73m2)
       * Liver disease (cirrhosis with portal hypertension)
       * Cerebral microbleeds ≥ 5
       * Stroke or transient ischemic attacks within 6 months or Transient amaurosis fugax
       * Incidence of nontraumatic intracerebral hemorrhage regardless of duration or incidence of traumatic intracerebral hemorrhage within 12 months

Exclusion Criteria:

1. Incidence of net clinical events, including cardiovascular and cerebrovascular accidents or major bleeding events, within 30 days following carotid artery stenting
2. Discontinuation of dual antiplatelet therapy within 30 days after carotid stent implantation (However, use of a single antiplatelet therapy within 7 days due to acute infection and trauma is allowed, but dual antiplatelet therapy must be administered at 28 to 30 days after carotid stent implantation)
3. Coronary artery stenting or other vascular stenting or vascular recanalization within 1 year (Revascularization surgery that requires CABG(Coronary Artery Bypass Graft) and other dual antiplatelet therapy)
4. Aspirin or clopidogrel hypersensitivity
5. Pregnant or breastfeeding women (Women of childbearing need to check for pregnancy using urine or blood tests before enrollment, and use appropriate contraception methods during the clinical trial period)
6. Patients requiring anticoagulation for ≥12 months
7. Patients requiring administration of other antiplatelet therapies
8. Patients who are participating in another intervention clinical trial

Where it's running

• Samsung Medical Center
  Seoul, South Korea Recruiting

Study contacts

• Study coordinator: Woo-Keun Seo, Ph.D
• Email: mcastenosis@gmail.com
• Phone: 82-2-3410-0799

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Carotid ultrasound to guide prevention of heart disease in inflammatory rheumatic diseases

  In people with inflammatory rheumatic diseases like RA, PsA, AxSpA, or SLE who are at modest cardiovascular risk, a carotid ultrasound test is used to see if they should start stronger lipid-lowering therapy to prevent heart problems.

  Recruiting at 7 sites Phase 4 Instituto de Investigación Marqués de Valdecilla · Alicante, Alicante and 16 other locations · NCT07611747

• Long-term follow-up of Intergard vascular grafts and patches

  This registry will see how Intergard grafts and patches perform and stay safe over time in adults who had bypass, repair, or replacement of the aorta, carotid, or peripheral arteries.

  Recruiting at 5 sites Intervascular · Hershey, Pennsylvania and 4 other locations · NCT07322913

• Mouth bacteria and carotid artery plaque vulnerability

  This project will see if mouth bacteria are linked to vulnerable carotid plaques in adults having carotid endarterectomy at Semmelweis University.

  Recruiting Semmelweis University Heart and Vascular Center · Budapest · NCT07296965

• SkyRunner carotid IVL before trans-carotid stenting for calcified carotid arteries

  This study tests the Shockwave SkyRunner carotid intravascular lithotripsy system to treat calcified carotid arteries before placing a trans-carotid stent in adults who are at high risk for traditional surgery.

  Recruiting at 17 sites Shockwave Medical, Inc. · Little Rock, Arkansas and 24 other locations · NCT07062471

• Evaluating a new system for protecting the brain during carotid artery procedures

  This study is testing a new device to see if it can help protect the brain during carotid artery procedures for people with narrowed arteries.

  Recruiting Shenzhen Wecan Medical Technology Co.,Ltd · Beijing · NCT06959628

• Monitoring blood flow during carotid surgery

  This study is testing a new way to manage blood flow during carotid surgery to see if it helps patients have better outcomes compared to standard treatment.

  Recruiting Fondazione Policlinico Universitario Agostino Gemelli IRCCS · Rome · NCT06926010

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.